MENU
NAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Niagen Bioscience (NAGE) Ownership - Who owns Niagen Bioscience?
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research... Show more
Industry: #Chemicals Specialty
Profile
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.02B
P/E Ratio
71.94
Total Cash
55.46M
Projected Growth
N/A
Total Debt
3.52M
Revenue
107.93M
Risk (Beta)
2.19
Dividend Yield
N/A
Total Cash/Share
0.70
Total Debt/Equity
N/A
Revenue/Share
1.35 USD as % of share price
Fundamentals
NAGE
Capitalization
1.02B
P/E Ratio
71.94
Risk (Beta)
2.19
Dividend Yield
N/A
Total Cash
55.5M
Total Cash/Share
0.70
Total Debt
3.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.35%
Revenue
108M
ROE
N/A
Book Value
55.3M
P/B Ratio
18.42
Cash Flow
N/A
Earnings
0.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
78K
Current Ratio
3.66
Current Revenue Per Employee
293086.53
Dividends Per Share - Security
N/A
EBITDA
14.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
63.42
Revenue To Assets
20.83
Shares Held By Institutions
186M
Shares Outstanding - Current
78.8M
Total Liabilities
26M
Total Volume MTD
N/A
Value
-1
Gain YTD
144.109
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of proprietary-based ingredient technologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A